Effects of a Nitric Oxide Donor on Tumor Blood Flow and Oxygenation
Author Information
Author(s): SQ Shan, GL Rosner, RD Braun, J Hahn, C Pearce, MW Dewhirst
Primary Institution: Duke University Medical Center
Hypothesis
Systemic changes in cardiovascular function induced by DEA/NO administration would lead to alterations in tumour perfusion and oxygenation.
Conclusion
The study found that intravenous injection of DEA/NO decreases mean arterial pressure and heart rate, leading to subsequent decreases in tumour blood flow and oxygenation.
Supporting Evidence
- DEA/NO reduced mean arterial pressure when given at doses ≥100 nmol kg-1.
- At doses ≥100 nmol kg-1, DEA/NO reduced tumor blood flow and constricted tumor arterioles.
- Significant vasomotion in tumor arterioles occurred during hypotension.
- Intratumoral pO2 dropped significantly after DEA/NO administration.
Takeaway
When a special drug was given to rats, it made their blood pressure drop, which caused less blood and oxygen to reach their tumors.
Methodology
The study used Fischer-344 rats with implanted tumors to measure blood flow and oxygen levels after administering different doses of DEA/NO.
Limitations
The study was conducted on rats, which may not fully represent human responses.
Participant Demographics
Fischer-344 rats weighing 130-180 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website